Brad Prather, MD
Orthopaedic Surgery · Danville, INNPI 1952445710
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,718 of the $5,703 with a category attached, or 65.2%. Smith+Nephew accounts for 92.4% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $2,347, 8.6 times the $274 reported in 2019.
Across 51 payments — averaging $111.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$5K
- Medtronic$162
- Ferring Pharmaceuticals Inc.$120
- Vertex$55
- DJO, LLC$42
- Johnson & Johnson$21
- plus $31 from 2 others
What the payments were for
- Travel & lodging$3,71865%
- Food & beverage$1,98535%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 33 | $5,272 |
| Medtronic | 4 | $162 |
| Ferring Pharmaceuticals Inc. | 7 | $120 |
| Vertex | 2 | $55 |
| DJO, LLC | 2 | $42 |
| Johnson & Johnson | 1 | $21 |
| Zimmer Biomet | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$3,298
- RI.HIP NAVIGATION$2,493
- JOURNEY$2,430
- REAL INTELLIGENCE$1,471
- Legion Revision$1,151
- OR3O Dual Mobility$1,151
- CORI$719
- POLARSTEM$610
- LEGION TKS$605
- VISIONAIRE$393
- Journey II CR$393
- Journey II BCS$212
- AQUAMANTYS$133
How this compares
$5,703 in reported general payments places this provider in the 55th percentile of 400 orthopaedic surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 17 | $461 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $302 |
| Oxycodone Hcl | 40 | $281 |
| Tramadol Hcl | 53 | $251 |
| Diclofenac Sodium | 12 | $213 |
| Meloxicam | 68 | $158 |
| Amoxicillin | 59 | $71 |
| Clindamycin Hcl | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Danville
- Frank KolisekGreenwood$7.5M
- David FisherIndianapolis$5.9M
- Michael BerendIndianapolis$4M
- John WilliamsFort Wayne$2.7M
- Sanford KunkelIndianapolis$1.9M
- Hill HastingsIndianapolis$1.6M
- Mark KlaassenElkhart$1.3M
- Alan McGeeFort Wayne$1.1M
- Lindsey RolstonNew Castle$1.1M
- John MedingMooresville$998K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.